Methyl 4-bromo-6-formylpicolinate

Catalog No.: 
ACTTBM865
CAS No.: 
1206249-70-8
Molecular Formula: 
C8H6BrNO3
Molecular Weight: 
244.04
Methyl 4-bromo-6-formylpicolinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$81.00InquiryInquiry
100mg98%$137.00InquiryInquiry
250mg98%$260.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-bromo-6-formylpicolinate
IUPAC Namemethyl 4-bromo-6-formylpicolinate
Molecular FormulaC8H6BrNO3
Molecular Weight244.04
SMILESO=C(OC)C1=NC(C=O)=CC(Br)=C1
InChI KeyVDFRUVJKUCTBKU-UHFFFAOYSA-N
Synonym2-Pyridinecarboxylic acid, 4-bromo-6-formyl-, methyl ester;Methyl 4-bromo-6-formylpicolinate
CAS No.1206249-70-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTTBM865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEFXV290 route compound structure diagram
    ACEFXV2901842336-50-8In Stock
  2. Then
  3. ACTTBM865 route product structure diagram
    ACTTBM8651206249-70-8
Inquiry

2. ACTTBM865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVTJE079 route compound structure diagram
    ACVTJE0791206248-47-6In Stock
  4. Then
  5. ACTTBM865 route product structure diagram
    ACTTBM8651206249-70-8
Inquiry

3. ACTTBM865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNUFX963 route compound structure diagram
    ACNUFX96329681-42-3In Stock
  4. Then
  5. ACTTBM865 route product structure diagram
    ACTTBM8651206249-70-8
Inquiry

Comments (0)